DNMRDanimer Scientific, Inc.

NYSE danimerscientific.com


$ 0.80 $ 0.04 (5.01 %)    

Friday, 03-May-2024 15:59:52 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 0.8051
$ 0.77
$ 0.00 x 0
$ 0.00 x 0
$ 0.77 - $ 0.85
$ 0.60 - $ 3.56
1,172,903
na
82.12M
$ 2.34
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-10-2023 03-31-2023 10-Q
5 03-28-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-10-2022 03-31-2022 10-Q
9 03-07-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-18-2021 03-31-2021 10-Q
13 03-30-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 07-31-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 danimer-scientific-announces-proposed-pro-rata-distribution-of-warrants-to-purchase-common-stock

Danimer Scientific, Inc. (NYSE:DNMR) ("Company" or "Danimer Scientific"), a leading next generation bioplastics...

 danimer-scientific-announces-20m-asset-based-revolving-credit-facility

The agreement, among other things, also allows for increases in the commitment up to an additional $5 million and matures on or...

 piper-sandler-downgrades-danimer-scientific-to-neutral-lowers-price-target-to-125

Piper Sandler analyst Charles Neivert downgrades Danimer Scientific (NYSE:DNMR) from Overweight to Neutral and lowers the pr...

 td-cowen-maintains-buy-on-danimer-scientific-lowers-price-target-to-2

TD Cowen analyst Thomas Boyes maintains Danimer Scientific (NYSE:DNMR) with a Buy and lowers the price target from $3 to $2.

 danimer-scientific-q4-2023-gaap-eps-039-misses-038-estimate-sales-10900m-miss-11333m-estimate

Danimer Scientific (NYSE:DNMR) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(...

 earnings-scheduled-for-march-28-2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

 reported-earlier-danimer-scientific-announced-15m-registered-direct-offering

Danimer Scientific, Inc. (NYSE:DNMR) (the "Company" or "Danimer Scientific"), a leading next generation bioplas...

 top-5-materials-stocks-that-are-ticking-portfolio-bombs

As of March 5, 2024, five stocks in the materials sector could be flashing a real warning to investors who value momentum as a ...

 danimer-scientific-announces-successful-expansion-of-rinnovo-demonstration-plant-capacity-newly-completed-plant-capacity-will-accelerate-partnership-testing

Newly completed demonstration plant capacity will accelerate partnership testingDanimer Scientific, Inc. (NYSE:DNMR) ("Dani...

 danimer-scientific-reveals-receipt-of-continued-listing-standard-notice-from-nyse

On January 26, 2024, the Company notified the NYSE that it intends to cure the stock price deficiency and return to compliance ...

 danimer-scientific-q3-eps-039-vs-094-last-year-sales-1095m-miss-1474m-estimate

Danimer Scientific (NYSE:DNMR) reported quarterly losses of $(0.39) per share. This is a 58.51 percent increase over losses of ...

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION